Corcept sells treatment for Cushing's syndrome.
Corcept Therapeutics Incorporated (CORT) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 16:08 ET. Consensus EPS estimate is $0.79.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | Jun 2026 qtr | $0.02 | $0.40 | — | $256.15M |
| 2026-04-30 | Mar 2026 qtr | $-0.11 | $-0.30 | — | $164.90M |
| 2026-02-24 | Dec 2025 qtr | $0.33 | $0.23 | — | $202.12M |
| 2025-11-04 | Sep 2025 qtr | $0.18 | $0.19 | +5.6% | $207.64M |
| 2025-07-31 | Jun 2025 qtr | $0.23 | $0.33 | — | $194.43M |
| 2025-05-05 | Mar 2025 qtr | $0.17 | $0.19 | +11.8% | $157.21M |
| 2025-02-26 | Dec 2024 qtr | $0.37 | $0.29 | — | $181.89M |
| 2024-10-30 | Sep 2024 qtr | $0.28 | $0.45 | — | $182.55M |
CORT has beaten consensus EPS in 2 of its last 2 scored quarters.
See CORT on the live calendar →